| - Therapy - | - Bleeding risk - | - Reference - |
| Anticoagulation | 9–26 % per year | |
| DAPT | 0.9–1.7 % per year according to amount of hemosiderosis | https://pmc.ncbi.nlm.nih.gov/articles/PMC8478107/ |
| in general population 5.8 % in the first month | https://pmc.ncbi.nlm.nih.gov/articles/PMC5818163/ | |
| Aspirin | 0.7–3.2 % per year according to amount of hemosiderosis | https://pmc.ncbi.nlm.nih.gov/articles/PMC8478107/ |
Prothromplex 17 ml jedna lahvička, podat rychlostí 120 ml/h